Ads
related to: Abbvie- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- Supporting Our Workforce
Embracing Equality & Diversity
Makes Us More Innovative.
- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- AbbVie News Center
Search results
FY2025 EPS Estimates for AbbVie Inc. (NYSE:ABBV) Lowered by Analyst
ETF DAILY NEWS· 5 hours agoAbbVie Inc. (NYSE:ABBV – Free Report) – Investment analysts at William Blair dropped their FY2025 EPS estimates for shares of AbbVie in a report released ...
Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
Zacks via Yahoo Finance· 18 hours agoAbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings...
AbbVie Inc. (NYSE:ABBV) to Post Q1 2024 Earnings of $2.21 Per Share, William Blair Forecasts
ETF DAILY NEWS· 6 hours agoAbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at William Blair issued their Q1 2024 EPS estimates for AbbVie in a research note issued to investors ...
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
Investor's Business Daily· 12 hours agoAbbVie stock has slumped 9% off its record high in March and is facing increasingly steep...
AbbVie buyout Cerevel marks trial win for Parkinson’s drug
Seeking Alpha· 2 days agoAbbVie's (ABBV) buyout target, Cerevel Therapeutics (CERE), announced positive data for its...
15 Best Monthly Dividend Stocks To Buy Right Now
Insider Monkey via Yahoo Finance· 4 days agoIn this article, we discuss 15 best monthly dividend stocks to buy right now. You can skip our detailed analysis of dividend stocks and their previous...
AbbVie-bound Cerevel reports phase 3 Parkinson's victory in early win for $8.7B deal
FierceBiotech· 2 days agoThe backing singer in AbbVie’s $8.7 billion takeover of Cerevel Therapeutics is having its moment in...
Counterfeit Botox linked to illnesses in nine states
The Independent via Yahoo News· 2 days agoCounterfeit Botox shares similarities to the FDA-approved Botox manufactured by AbbVie. However, Botox made by AbbVie displays their product description...
AbbVie stock gains as Rinvoq succeeds in giant cell arteritis
Seeking Alpha· 2 days agoAbbVie (ABBV) stock gains as the company's JAK inhibitor, upadacitinib, succeeds in a Phase 3 trial...
Is AbbVie a Millionaire Maker?
Motley Fool via Yahoo Finance· 6 days agoBig pharma stocks like AbbVie (NYSE: ABBV) usually aren't high on the list that investors look to for opportunities that could make them into...
Ad
related to: Abbvie